Universitätsklinikum Essen

Tumor Immunology The new fourth Pillar of Tumor Treatment (2021) Kasper S, Rammensee HG, Gaipl U, Hoeffken K Journal article, Editorial Encorafenib, binimetinib plus pembrolizumab triplet therapy in patients with advanced BRAF(V600) mutant melanoma: safety and tolerability results from the phase I IMMU-TARGET trial (2021) Zimmer L, Livingstone E, Krackhardt A, Schultz ES, Goppner D, Assaf C, Trebing D, et al. Journal article Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis (2021) Zaremba A, Kramer R, De Temple V, Bertram S, Salzmann M, Gesierich A, Reinhardt L, et al. Journal article Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia (2021) Rautenberg C, Stoelzel F, Roellig C, Stelljes M, Gaidzik V, Lauseker M, Kriege O, et al. Journal article RESULTS OF THE IELSG32 TRIAL AT A MEDIAN FOLLOW-UP OF 88 MONTHS DEMONSTRATE THAT MATRIX FOLLOWED BY AUTOLOGOUS TRANSPLANT IS ASSOCIATED WITH EXCELLENT SURVIVAL AND NEUROTOLERABILITY IN PATIENTS WITH PRIMARY CNS LYMPHOMA (2021) Calimeri T, Cwynarski K, Pulczynski E, Fox CP, Schorb E, Steffanoni S, Foppoli M, et al. Conference contribution Cardiovascular autonomic dysfunction in patients with posterior circulation ischemic stroke (2021) Wang R, Macha K, Koehn J, Siedler G, Winder K, Gerner S, Schwab S, et al. Conference contribution Screening for Palliative Care Needs: Pilot Data From German Comprehensive Cancer Centers (2021) Roch C, Heckel M, Van Oorschot B, Alt-Epping B, Tewes M Journal article Fertility preservation and management of pregnancy in melanoma patients requiring systemic therapy (2021) Hassel JC, Livingstone E, Allam JP, Behre HM, Bojunga J, Klein HH, Landsberg J, et al. Journal article, Review article Dokumentation der Psoriasis in der Routineversorgung – Expertenkonsens zu einem deutschen Datensatz (2021) Otten M, Mrowietz U, von Kiedrowski RM, Otto R, Altenburg A, Aschoff R, Beissert S, et al. Journal article EARLY CHILDHOOD HEIGHT-ADJUSTED TOTAL KIDNEY VOLUME AS A RISK MARKER OF KIDNEY SURVIVAL IN AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE (ARPKD) (2021) Burgmaier K, Kilian S, Arbeiter K, Atmis B, Buescher A, Derichs U, Dursun I, et al. Conference contribution